Mucosal immunity to viruses

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 799-813

  Murphy, Brian R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882826902     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50047-4     Document Type: Chapter

References (204)

1. Anderson J.J., Norden J., Saunders D., Toms G.L., Scott R. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection. J. Gen. Virol. 1990, 71:1561-1570.
2. Arulanandam B.P., Raeder R.H., Nedrud J.G., Bucher D.J., Le J., Metzger D.W. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection. J. Immunol. 2001, 166(1):226-231.
3. Asahi Y., Yoshikawa T., Watanabe I., Iwasaki T., Hasegawa H., Sato Y., Shimada S., Nanno M., Matsuoka Y., Ohwaki M., Iwakura Y., Suzuki Y., Aizawa C., Sata T., Kurata T., Tamura S. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 2002, 168(6):2930-2938.
4. Asanuma H., Aizawa C., Kurata T., Tamura S. IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. Vaccine 1998, 16(13):1257-1262.
5. Aung S., Rutigliano J.A., Graham B.S. Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease. J. Virol. 2001, 75(20):9918-9924.
6. Baumgarth N., Herman O.C., Jager G.C., Brown L.E., Herzenberg L.A., Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 2000, 192(2):271-280.
7. Belec L., Tevi-Benissan C., Dupre T., Mohamed A.S., Prazuck T., Gilquin J., Kanga J.M., Pillot J. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection. J. Clin. Immunol. 1996, 16(1):12-20.
8. +)-T-cell-deficient mice. J. Virol. 2002, 76(23):12388-12393.
9. Benton K.A., Misplon J.A., Lo C.Y., Brutkiewicz R.R., Prasad S.A., Epstein S.L. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. J. Immunol. 2001, 166(12):7437-7445.
10. Besser T.E., Gay C.C., McGuire T.C., Evermann J.F. Passive immunity to bovine rotavirus infections associated with transfer of serum antibody into the intestinal lumen. J. Virol. 1988, 62:2238-2242.
11. Bishop R., Lund J., Cipriani E., Unicomb L., Barnes G. Clinical serological and intestinal immune responses to rotavirus infection of humans. Medical Virology 9 1990, Plenum Press, New York. L.M. de la Maza, E.M. Peterson (Eds.).
12. Blandford G., Heath R.B. Studies on the immune response and pathogenesis of Sendai virus infection of mice. I. The fate of viral antigens. Immunology 1972, 22(4):637-649.
13. Bodian D., Nathanson N. Inhibitory effects of passive antibody on virulent poliovirus excretion and on immune response in chimpanzees. Bull. Johns Hopkins Hosp. 1960, 107:143-162.
14. Bomsel M., Heyman M., Hocini H., Lagaye S., Belec L., Dupont C., Desgranges C. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 1998, 9(2):277-287.
15. Bot A., Reichlin A., Isobe H., Bot S., Schulman J., Yokoyama W.M., Bona C.A. Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. J. Virol. 1996, 70(8):5668-5672.
16. Bowman E.P., Kuklin N.A., Youngman K.R., Lazarus N.H., Kunkel E.J., Pan J., Greenberg H.B., Butcher E.C. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J. Exp. Med. 2002, 195(2):269-275.
17. Brown K.A., Kriss J.A., Moser C.A., Wenner W.J., Offit P.A. Circulating rotavirus-specific antibody-secreting cells (ASCs) predict the presence of rotavirus-specific ASCs in the human small intestinal lamina propria. J. Infect. Dis. 2000, 182(4):1039-1043.
18. Brown T.A., Clements M.L., Murphy B.R., Radl J., Haaijman J.J., Mestecky J. Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccines. Adv. Exp. Med. Biol. 1987, 216B:1691-1700.
19. Brown T.A., Murphy B.R., Radl J., Haaijman J.J., Mestecky J. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J. Clin. Microbiol. 1985, 22:259-264.
20. Burlington D.B., Clements M.L., Meiklejohn G., Phelan M., Murphy B.R. Hemagglutinin specific antibody responses in the IgG, IgA and IgM isotypes as measured by ELISA after primary or secondary infection of man with influenza A virus. Infect. Immunol. 1983, 41:540-545.
21. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., Greenberg H.B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996, 272(5258):104-107.
22. Burton D.R. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2002, 2(9):706-713.
23. Buscho R.F., Perkins J.C., Knopf J.L.S., Kapikian A.Z., Chanock R. Further characterization of the local respiratory tract antibody response induced by intransal instillation of inactivated rhinovirus 13 vaccine. J. Immunol. 1972, 108:169-177.
24. Butcher E.C., Williams M., Youngman K., Rott L., Briskin M. Lymphocyte trafficking and regional immunity. Adv. Immunol. 1999, 72:209-253.
25. Buttinelli G., Ruggeri F.M., Marturano J., Novello F., Donati V., Fiore L. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice. Virology 2001, 281(2):265-271.
26. Cannon M.J., Openshaw P.J., Askonas B.A. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 1988, 168:1163-1168.
27. Cerwenka A., Morgan T.M., Dutton R.W. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 1999, 163(10):5535-5543.
28. Chen K.S., Burlington D.B., Quinnan G.V. Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine. J. Virol. 1987, 61:2150-2154.
29. Clements M.L., Betts R.F., Tierney E.L., Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 1986, 24:157-160.
30. Clements M.L., Murphy B.R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J. Clin. Microbiol. 1986, 23:66-72.
31. Clements M.L., O'Donnell S., Levine M.M., Chanock R.M., Murphy B.R. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reasortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect. Immun. 1983, 40:1044-1051.
32. Coffin S.E., Klinek M., Offit P.A. Induction of virus-specific antibody production by lamina propria lymphocytes following intramuscular inoculation with rotavirus. J. Infect. Dis. 1995, 172:874-878.
33. Conner M.E., Gilger M.A., Estes M.K., Graham D.Y. Serologic and mucosal immune response to rotavirus infection in the rabbit model. J. Virol. 1991, 65:2562-2571.
34. Connors M., Collins P.L., Firestone C.Y., Murphy B.R. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J. Virol. 1991, 65(3):1634-1637.
35. Corthier G., Vannier P. Production of coproantibodies and immune complexes in piglets infected with rotavirus. J. Infect. Dis. 1983, 147:293-296.
36. Coste A., Sirard J.C., Johansen K., Cohen J., Kraehenbuhl J.P. Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea. J. Virol. 2000, 74(19):8966-8971.
37. Coulson B.S., Grimwood K., Masendycz P.J., Lund J.S., Mermelstein N., Bishop R.F., Barnes G.L. Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood. J. Clin. Microbiol. 1990, 28:1367-1374.
38. Crowe J.E., Firestone C.Y., Murphy B.R. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines. J. Immunol. 2001, 167(7):3910-3918.
39. Czerkinsky C., Prince S.J., Mchalek S.M., Jackson S., Russell M.W., Moldoveanu Z., McGhee J.R., Mestecky J. IgA antibody-producing cells in peripheral blood after antigen ingestion: Evidence for a common mucosal immune system in humans. Proc. Natl. Acad. Sci. USA 1987, 84:2449-2453.
40. De St.Groth S.F., Donnelley M. Studies in experimental immunology of influenza. IV. The protective value of active immunization. Aust. J. Exp. Bio. Med. Sci. 1950, 28:61-75.
41. Dharakul T., Riepenhoff-Talty M., Albini B., Ogra P.L. Distribution of rotavirus antigen in intestinal lymphoid tissues: Potential role in development of the mucosal immune response to rotavirus. Clin. Exper. Immunol. 1988, 74:14-19.
42. + T lymphocytes. J. Virol. 1990, 64(9):4375-4382.
43. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 1997, 159:105-117.
44. + T cells. J. Exp. Med. 1991, 174:875-880.
45. Eichelberger M.C., Wang M., Allan W., Webster R.G., Doherty P.C. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J. Gen. Virol. 1991, 72:1695-1698.
46. Endo A., Itamura S., Iinuma H., Funahashi S.-L., Shida H., Koide F., Nerome K., Oya A. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein gene of influenza virus. J. Gen. Virol. 1991, 72:699-703.
47. Feng N., Lawton J.A., Gilbert J., Kuklin N., Vo P., Prasad B.V., Greenberg H.B. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J. Clin. Invest. 2002, 109(9):1203-1213.
48. Feng N., Vo P.T., Chung D., Vo T.-V.P., Hoshino Y., Greenberg H.B. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model. J. Infect. Dis. 1997, 175:330-341.
49. Fisher R.G., Crowe J.E., Johnson T.R., Tang Y.W., Graham B.S. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus. J. Infect. Dis. 1999, 180(4):1324-1327.
50. + T cells in primary and secondary influenza pneumonia. Immunity 1998, 8(6):683-691.
51. Franco M.A., Greenberg H.B. Immunity to rotavirus infection in mice. J. Infect. Dis. 1999, 179(Suppl 3):S466-S469.
52. Friedman M.G. Radioimmunoassay for the detection of virus-specific IgA antibodies in Saliva. J. Imunol. Meth. 1982, 54:203-211.
53. Friedman M.G., Phillip M., Dagan R. Virus-specific IgA in serum, saliva, and tears of children with measles. Clin. Exp. Immunol. 1989, 75:58-63.
54. Fujioka H., Emancipator S.N., Aikawa M., Huang D.S., Blatnik F., Karban T., DeFife K., Mazanec M.B. Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium. J. Exp. Med. 1998, 188(7):1223-1229.
55. Gaddum R.M., Cook R.S., Wyld S.G., Lopez J.A., Bustos R., Melero J.A., Taylor G. Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection. J. Gen. Virol. 1996, 77:1239-1248.
56. Galletti R., Beauverger P., Wild T.F. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses. Vaccine 1995, 13:197-201.
57. Gerhard W. The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol. 2001, 260:171-190.
58. Giammarioli A.M., Mackow E.R., Fiore L., Greenberg H.B., Ruggeri F.M. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus. Virology 1996, 225:97-110.
59. Gonzalez A.M., Jaimes M.C., Cajiao I., Rojas O.L., Cohen J., Pothier P., Kohli E., Butcher E.C., Greenberg H.B., Angel J., Franco M.A. Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor α4β7. Virology 2003, 305(1):93-105.
60. Grimwood K., Lund J.C.S., Coulson B.S., Hudson I.L., Bishop R.F., Barnes G.L. Comparison of serum and mucosal antibody responses following severe acute rotivirus gastroenteritis in young children. J. Clin. Microbiol. 1988, 26:732-738.
61. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996, 4(1):25-36.
62. Haan L., Verweij W.R., Holtrop M., Brands R., van Scharrenburg G.J., Palache A.M., Agsteribbe E., Wilschut J. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. Vaccine 2001, 19(20-22):2898-2907.
63. Haneberg B., Kendall D., Amerongen H.M., Apter F.M., Kraehenbuhl J.P., Neutra M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 1994, 62:15-23.
64. Heinen P.P., van Nieuwstadt A.P., Pol J.M., de Boer-Luijtze E.A., van Oirschot J.T., Bianchi A.T. Systemic and mucosal isotype-specific antibody responses in pigs to experimental influenza virus infection. Viral Immunol. 2000, 13(2):237-247.
65. Herremans T.M., Reimerink J.H., Buisman A.M., Kimman T.G., Koopmans M.P. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J. Immunol. 1999, 162(8):5011-5018.
66. Hicks J.T., Ennis F.A., Kim E., Verbonitz M. The importance of an intact complement pathway in recovery from a primary viral infection: Influenza in decomplemented and in C5-deficient mice. J. Immunol. 1978, 121:1437-1445.
67. Hirabayashi Y., Kurata H., Funato H., Nagamine T., Aizawa C., Tamura S.-I., Shimada K., Kurata T. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 1990, 8:243-249.
68. Hjelt K., Grauballe P.C., Paerregaard A., Nielsen O.H., Krasilnikoff P.A. Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J. Med. Virol. 1987, 21:39-47.
69. + T cells in the lung airways depends on proliferation. J. Immunol. 2002, 169(9):4976-4981.
70. + T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 2001, 166(3):1813-1822.
71. Huber V.C., Lynch J.M., Bucher D.J., Le J., Metzger D.W. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J. Immunol. 2001, 166(12):7381-7388.
72. Jayashree S., Bhan M.K., Kumar R., Raj P., Glass R., Bhandari N. Serum and salivary antibodies as indicators of rotavirus infection in neonates. J. Infect. Dis. 1988, 158:1117-1119.
73. Johnson M.P., Meitin C.A., Bender B.S., Small P.A. Passive immune serum inhibits antibody response to recombinant vaccinia virus. Vaccines 88: Modern Approaches to New Vaccines, Including Prevention of AIDS 1988, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. R.M. Chanock, R.A. Lerner, F. Brown, H. Ginsberg (Eds.).
74. Johnson P.R., Feldman S., Thompson J.M., Mahoney J.D., Wright P.F. Immunity to influenza A virus infection in young children: a comparison of natural infection, live coldadapted vaccine, and inactivated vaccine. J. Infect. Dis. 1986, 154(1):121-127.
75. Jones P.D., Ada G.L. Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection. J. Virol. 1986, 60:614-619.
76. Kaetzel C.S., Robinson J.K., Lamm M.E. Epithelial transcytosis of monomeric IgA and IgG cross-linked through antigen to polymeric IgA. A role for monomeric antibodies in the mucosal immune system. J. Immunol. 1994, 152(1):72-76.
77. Kagi D., Seiler P., Pavlovic J., Ledermann B., Burki K., Zinkernagel R.M., Hengartner H. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 1995, 25(12):3256-3262.
78. Kast W.M., Bronkhorst A.M., deWaal L.P., Melief C.J. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations. J. Exp. Med. 1986, 164(3):723-738.
79. Kaul T.N., Welliver R.C., Wong D.T., Udwadia R.A., Riddlesberger K., Ogra P.L. Secretory antibody response to respiratory syncytial virus infection. Am. J. Dis. Child. 1981, 135:1013-1016.
80. Keller R., Dwyer J.E. Neutralization of poliovirus by IgA coproantibodies. J. Immunol. 1968, 101:192-202.
81. Kimman T.G., Westenbrink F. Immunity to human and bovine respiratory syncytial virus. Arch. Virol. 1990, 112:1-25.
82. Kimman T.G., Westenbrink F., Schreuder B.E., Straver P.J. Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies. J. Clin. Microbiol. 1987, 25(6):1097-1106.
83. Kimman T.G., Westenbrink F., Straver P.J. Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet. Immunol. Immunopathol. 1989, 22(2):145-160.
84. Klasse P.J., Sattentau Q.J. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 2002, 83:2091-2108. (Pt 9).
85. Knossow M., Gaudier M., Douglas A., Barrere B., Bizebard T., Barbey C., Gigant B., Skehel J.J. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 2002, 302(2):294-298.
86. Kopf M., Brombacher F., Bachmann M.F. Role of IgM antibodies versus B cells in influenza virus-specific immunity. Eur. J. Immunol. 2002, 32(8):2229-2236.
87. +) T cell-mediated intestinal immunity to rotavirus. J. Clin. Invest. 2000, 106(12):1541-1552.
88. Kuklin N.A., Rott L., Feng N., Conner M.E., Wagner N., Muller W., Greenberg H.B. Protective intestinal antirotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not required IgA antibody production. J. Immunol. 2001, 166(3):1894-1902.
89. Kunkel E.J., Butcher E.C. Chemokines and the tissuespecific migration of lymphocytes. Immunity 2002, 16(1):1-4.
90. Lawson C.M., Bennink J.R., Restifo N.P., Yewdell J.W., Murphy B.R. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J. Virol. 1994, 68(6):3505-3511.
91. Lepow M.L., Warren R.J., Gray N., Ingram V.G., Robbins F.C. Effect of Sabin type 1 poliomyelitis vaccine administered by mouth to newborn infants. N. Engl. J. Med. 1961, 264:1071-1078.
92. Leung K.N., Ada G.L. Cells mediating delayed-type hypersensitivity in the lungs of mice infected with an influenza A virus. Scandinavian Journal of Immunology 1980, 12:393-400.
93. Liang B., Hyland L., Hou S. Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice. J. Virol. 2001, 75(11):5416-5420.
94. Liang X.P., Lamm M.E., Nedrud J.G. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol. 1988, 141(5):1495-1501.
95. Liew F.Y., Russell S.M., Appleyard G., Brand C.M., Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather that serum antibody or cytoxic T cell reactivity. Eur. J. Immunol. 1984, 14:350-356.
96. + T cells act as effector cells in protection against influenza virus infection?. Immunology 1987, 62(1):139-144.
97. Ludert J.E., Ruiz M.C., Hidalgo C., Liprandi F. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation. J. Virol. 2002, 76(13):6643-6651.
98. Lyn D., Mazanec M.B., Nedrud J.G., Portner A. Location of amino acid residues important for the structure and biological function of the haemagglutinin-neuraminidase glycoprotein of Sendai virus by analysis of escape mutants. J. Gen. Virol. 1991, 72:817-824.
99. + cytotoxic T cells. Immunology 1989, 67:375-381.
100. Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991, 353:321-325.
101. Maoliang W. Production of IgA monoclonal antibodies against influenza A virus. J. Virol. Method 1986, 13:21-26.
102. Matson D.O., O'Ryan M.L., Herrera I., Pickering L.K., Estes M.K. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 1993, 167:577-583.
103. Mazanec M.B., Coudret C.L., Fletcher D.R. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 1995, 69(2):1339-1343.
104. Mazanec M.B., Kaetzel C.S., Lamm M.E., Fletcher D., Nedrud J.G. Intracellular neutralization of virus by immunolobulin A antibodies. Proc. Natl. Acad. Sci. USA 1992, 89:6901-6905. (15).
105. Mazanec M.B., Lamm M.E., Lyn D., Portner A., Nedrud J.G. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res. 1992, 23(1-2):1-12.
106. Mazanec M.B., Nedrud J.G., Lamm M.E. Immunoglobulin A monoclonal antibodies protect against Sendai virus. J. Virol. 1987, 61(8):2624-2626.
107. McBride B.W., Ward K.A. Herpes simplex-specific IgG subclass response in herpetic keratitis. J. Med. Virol. 1987, 21:179-189.
108. McDermott M.R., Lukacher A.E., Braciale V.L., Braciale T.J., Bienenstock J. Characterization and in vivo distribution of influenza-virus-specific T-lymphocytes in the murine respiratory tract. Am. Rev. Respir. Dis. 1987, 135(1):245-249.
109. McIntosh K., Masters H.B., Orr I., Chao R.K., Barkin R.M. The immunologic response to infection with respiratory syncytial virus in infants. J. Infect. Dis. 1978, 138(1):24-32.
110. McIntosh K., McQuillin J., Gardner P.S. Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect. Immun. 1979, 23(2):276-281.
111. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A.S. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 1983, 309:13-17.
112. McNeal M.M., VanCott J.L., Choi A.H., Basu M., Flint J.A., Stone S.C., Clements J.D., Ward R.L. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J. Virol. 2002, 76(2):560-568.
113. Merchant A.A., Groene W.S., Cheng E.H., Shaw R.D. Murine intestinal antibody response to heterologous rotavirus infection. J. Clin. Microbiol. 1991, 29:1693-1701.
114. Merriman H., Woods S., Winter C., Fahnlander A., Corey L. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus. J. Infect. Dis. 1984, 149:505-510.
115. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 1987, 7:265-276.
116. Mills J., Van Kirk J.E., Wright P.F., Chanock R.M. Experimental respiratory synytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J. Immunol. 1971, 107(1):123-130.
117. Munoz J.L., McCarthy C.A., Clark M.E., Hall C.B. Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells. J. Virol. 1991, 65(8):4494-4497.
118. Murphy B.R., Alling D.W., Snyder M.H., Walsh E.E., Prince G.A., Chanock R.M., Hemming V.G., Rodriguez W.J., Kim H.W., Graham B.S. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J. Clin. Microbiol. 1986, 24(5):894-898.
119. Murphy B.R., Chalhub E.G., Nusinoff S.R., Kasel J., Chanock R.M. Temperature-sensitive mutants of influenza virus. III. Further characterization of the ts-1 (E) influenza A recombinant (H3N2) virus in man. J. Infect. Dis. 1973, 128(4):479-487.
120. Murphy B.R., Collins P.L., Lawrence L., Zubak J., Chanock R.M., Prince G.A. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants. J. Gen. Virol. 1989, 70:2185-2190.
121. Murphy B.R., Graham B.S., Prince G.A., Walsh E.E., Chanock R.M., Karzon D.T., Wright P.F. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J. Clin. Microbiol. 1986, 23(6):1009-1014.
122. Murphy B.R., Nelson D.L., Wright P.F., Tierney E.L., Phelan M.A., Chanock R.M. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect. Immun. 1982, 36(3):1102-1108.
123. Murphy B.R., Olmsted R.A., Collins P.L., Chanock R.M., Prince G.A. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses. J. Virol. 1988, 62(10):3907-3910.
124. Murphy B.R., Prince G.A., Walsh E.E., Kim H.W., Parrott R.H., Hemming V.G., Rodriguez W.J., Chanock R.M. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J. Clin. Microbiol. 1986, 24(2):197-202.
125. Nedrud J.G., Liang X.P., Hague N., Lamm M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 1987, 139(10):3484-3492.
126. Nedrud J.G., Mazanec M.B., Liang X., Hague N., Lamm M.E. Induction and expression of respiratory IgA immunity against Sendai virus in mice. Adv. Exp. Med. Biol. 1987, 216B:1847-1854.
127. + cytotoxic T lymphocytes. J. Infect. Dis. 2001, 183(3):368-376.
128. Nicholas J.A., Rubino K.L., Levely M.E., Meyer A.L., Collins P.L. Cytotoxic T cell activity against the 22-KdA protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication. Virology 1991, 182(2):664-672.
129. Nishio O., Sumi J., Sakae K., Ishihara Y., Isomura S., Inouye S. Fecal IgA antibody responses after oral poliovirus vaccination in infants and elder children. Microbiol. Immunol. 1990, 34:683-689.
130. O'Neal C.M., Harriman G.R., Conner M.E. Protection of the villus epithellial cells of the small intestine from rotavirus infection does not require immunoglobulin A. J. Virol. 2000, 74(9):4102-4109.
131. Offit P.A., Dudzik K.I. Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J. Virol. 1990, 64:6325-6328.
132. Offit P.A., Shaw R.D., Greenberg H.B. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. J. Virol. 1986, 58:700-703.
133. Ogra P.L. Distribution of echovirus antibody in serum nasopharynx, rectum, and spinal fluid after natural infection with echovirus type 6. Infect. Immun. 1970, 2:150-155.
134. Ogra P.L., Coppola P.R., MacGillivray M.H., Dzierba J.L. Mechanism of mucosal immunity to viral infections in A immunoglobulin-deficiency syndromes. Proc. Soc. Exp. Biol. Med. 1974, 145:811-816.
135. Ogra P.L., Karzon D.T. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J. Immunol. 1969, 102:1423-1430.
136. Ogra P.L., Karzon D.T. Polivirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J. Immunol. 1969, 102:15-23.
137. Onorato I.M., Modlin J.F., McBean A.M., Thomas M.L., Losonsky G.A., Bernier R.H. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J. Infect. Dis. 1991, 163:1-6.
138. Outlaw M.C., Dimmock N.J. Insights into neutralization of animal viruses gained from study of influenza virus. Epidemiol. Infect. 1991, 106:205-220.
139. Palladino G., Mozdzanowska K., Washko G., Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 1995, 69(4):2075-2081.
140. Perkins J.C., Tucker D.N., Knopf H.L.S., Wenzel R.P., Kapikian A.Z., Chanock R.M. Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. Am. J. Epidemiol. 1969, 90:519-526.
141. Plotnicky-Gilquin H., Cyblat-Chanal D., Aubry J.P., Champion T., Beck A., Nguyen T., Bonnefoy J.Y., Corvaia N. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment. J. Virol. 2002, 76(20):10203-10210.
142. Ponzi A.N., Merlino C., Angeretti A., Penna R. Virus-specific polymeric immunoglobulin A antibodies in serum from patients with rubella, measles, varicella, and herpes zoster virus infections. J. Clin. Microbiol. 1985, 22:505-509.
143. Prince G.A., Hemming V.G., Horswood R.L., Baron P.A., Murphy B.R., Chanock R.M. Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats. J. Virol. 1990, 64(6):3091-3092.
144. Prince G.A., Horswood R.L., Chanock R.M. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J. Virol. 1985, 55(3):517-520.
145. Puck J.M., Glezen W.P., Frank A.L., Six H.R. Protection of infants from infection with influenza A virus by transplacetally acquired antibody. J. Infect. Dis. 1980, 142:844-849.
146. Ramphal R., Cogliano R.C., Shands J.W., Small P.A. Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis. Infect. Immun. 1979, 25:992-997.
147. Ray R., Glaze B.J., Moldoveanu Z., Compans R.W. Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3. J. Infect. Dis. 1988, 157(4):648-654.
148. Renegar K.B., Small P.A. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 1991, 146:1972-1978.
149. Reuman P.D., Ayoub E.M., Small P.A. Effect of passive maternal antibody on influenza illness in children: A prospective study of influenza A in mother-infant pairs. Pediatr. Infect. Dis. J. 1987, 6:398-403.
150. Reuman P.D., Keely S.P., Schiff G.M. Rapid recovery in mice after
151. Reuman P.D., Paganini C.M.A., Ayoub E.M., Small P.A. Maternal-infant transfer of influenza-specific immunity in the mouse. J. Immunol. 1983, 130:932-936.
152. +) T-cell responses in CD4-depleted Ig(-/-) mice. J. Virol. 2000, 74(20):9762-9765.
153. Richardson S.C., Bishop R.F. Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus. J. Clin. Microbiol. 1990, 28:1891-1897.
154. Richman D.D., Murphy B.R., Tierney E.L., Chanock R.M. Specificity of the local secretory antibody to influenza A virus infection. J. Immunol. 1974, 113(5):1654-1656.
155. + memory T cells to clear rotavirus infection. J. Virol. 1998, 72(1):726-730.
156. Rubin D.H., Anderson A.O., Lucis D. Potentiation of the secretory IgA response by oral and enteric administration of CP 20,961. Ann. NY Acad. Sci. 1983, 409:866-870.
157. Rudzik R., Clancy R.L., Perey D.Y.E., Day R.P., Bienenstock J. Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous Peyer's patch and bronchial lymphocytes. J. Immunol. 1975, 114:1599-1604.
158. Ruggeri F.M., Johansen K., Basile G., Kraehenbuhl J.P., Svensson L. Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J. Virol. 1998, 72(4):2708-2714.
159. Sabin A.B., Michaels R.H., Krugman S., Eiger M.E., Berman P.H., Warren J. Effect of oral poliovirus vaccine in newborn children. I. Excretion of virus after ingestion of large doses of type I or of mixture of all three types, in relation to level of placentally transmitted antibody. Pediatrics 1963, 31:623-640.
160. Sabin A.B., Michaels R.H., Ziring P., Krugman S., Warren J. Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type I vaccine at birth. Pediatrics 1963, 31:641-654.
161. Sanchez P.J. Immunoprophylaxis for respiratory syncytial virus. Pediatr. Infect. Dis. J. 2002, 21(5):473-478.
162. Scherle P.A., Palladino G., Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 1992, 148(1):212-217.
163. Schwartz-Cornil I., Benureau Y., Greenberg H., Hendrickson B.A., Cohen J. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J. Virol. 2002, 76(16):8110-8117.
164. Scott R.M., Dudding B.A., Romano S.V., Russell P.K. Enteric immunozation with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization. Infect. Immun. 1972, 5:300-304.
165. Shaw R.D., Groene W.S., Mackow E.R., Merchant A.A., Cheng E.H. VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection. J. Virol. 1991, 65:3052-3059.
166. Silvey K.J., Hutchings A.B., Vajdy M., Petzke M.M., Neutra M.R. Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches. J. Virol. 2001, 75(22):10870-10879.
167. Simeckova-Rosenberg J., Yun Z., Wyde P.R., Atassi M.Z. Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin. Vaccine 1995, 13(10):927-932.
168. Smith C.B., Purcell R.H., Bellanti J.A., Chanock R.M. Protective effect of antibody to parainfluenza type 1 virus. N. Engl. J. Med. 1966, 275(21):1145-1152.
169. Smith T.J., Buescher E.L., Top F.H., Altemeier W.A., McCown J.M. Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: Clinical and immunological responses. J. Infect. Dis. 1970, 122:239-248.
170. Sonza S., Holmes I.H. Coproantibody response to rotavirus infection. Med. J. Aust. 1980, 2:496-499.
171. Staats H.F., Nichols W.G., Pallker T.J. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 1996, 157(1):462-472.
172. Takao S.I., Kiyotani K., Sakaguchi T., Fujii Y., Seno M., Yoshida T. Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses. J. Virol. 1997, 71(1):832-838.
173. Tamura S., Iwasaki T., Thompson A.H., Asanuma H., Chen Z., Suzuki Y., Aizawa C., Kurata T. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. J. Gen. Virol. 1998, 79:291-299. (Pt 2).
174. Tamura S.-I., Funato H., Hirabayashi Y., Kikuta K., Suzuki Y., Nagamine T., Aizawa C., Nakagawa M., Kurata T. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine 1990, 8:479-485.
175. Taylor G., Thomas L.H., Wyld S.G., Furze J., Sopp P., Howard C.J. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J. Virol. 1995, 69(11):6658-6664.
176. Taylor P.M., Askonas B.A. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 1986, 58:417-420.
177. + T cell clones vary in function in vitro and in influenza infection in vivo. Int. Immunol. 1990, 2(4):323-328.
178. + T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 1997, 159(11):5197-5200.
179. Tsutsumi H., Matsuda K., Yamazaki H., Ogra P.L., Chiba S. Different kinetics of antibody responses between IgA and IgG classses in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. Acta Paediatr. Jpn. 1995, 37(4):464-468.
180. Valtanen S., Roivainen M., Piirainen L., Stenvik M., Hovi T. Poliovirus-specific intestinal antibody responses coincide with decline of poliovirus excretion. J. Infect. Dis. 2000, 182(1):1-5.
181. Varga S.M., Braciale T.J. RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology 2002, 295(2):203-207.
182. Wagner D.K., Clements M.L., Reimer C.B., Snyder M., Nelson D.L., Murphy B.R. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J. Clin. Microbiol. 1987, 25(3):559-562.
183. Waldman R.H., Kasel J.A., Fulk R.V., Togo Y., Hornick R.B., Heiner G.G., Dawkins A.T., Mann J.J. Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus. Nature 1968, 218:594-595.
184. Waldman R.H., Stone J., Bergmann K.C., Khakoo R., Lazzell V., Jacknowitz A., Waldman E.R., Howard S. Secretory antibody following oral influenza immunization. Am. J. Med. Sci. 1986, 292:367-371.
185. Waldman R.H., Wood S.H., Torres E.J., Small P.A. Influenza antibody response following aerosol administration of inactivated virus. Am. J. Epidemiol. 1970, 91:575-584.
186. Ward R.L., Bernstein D.I., Shukla R., McNeal M.M., Sherwood J.R., Young E.C., Schiff G.M. Protection of adults rechallenged with a human rotavirus. J. Infect. Dis. 1990, 161:440-445.
187. Ward R.L., Bernstein D.I., Shukla R., Young E.C., Sherwood J.R., McNeal M.M., Walker M.C., Schiff G.M. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J. Infect. Dis. 1989, 159:79-88.
188. Watt P.J., Robinson B.S., Pringle C.R., Tyrrell D.A. Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines. Vaccine 1990, 8(3):231-236.
189. Webster R.G., Kawaoka Y., Taylor J., Weinberg R., Paoletti E. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 1991, 9:303-308.
190. Weltzin R., Lucia-Jandris P., Michetti P., Fields B.N., Kraehenbuhl J.P., Neutra M.R. Binding and transepithelial transport of immunoglobulins by intestinal M cells: Demonstration using monoclonal IgA antibodies against enteric viral proteins. J. Cell Biol. 1989, 108:1673-1685.
191. Wright P.F., Karron R.A., Belshe R.B., Thompson J., Crowe J.E., Boyce T.G., Halburnt L.L., Reed G.W., Whitehead S.S., Anderson E.L., Wittek A.E., Casey R., Eichelberger M., Thumar B., Randolph V.B., Udem S.A., Chanock R.M., Murphy B.R. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J. Infect. Dis. 2000, 182(5):1331-1342.
192. Wright P.F., Murphy B.R., Kervina M., Lawrence E.M., Phelan M.A., Karzon D.T. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect. Immun. 1983, 40(3):1092-1095.
193. Yamaguchi H., Inouye S., Yamauchi M., Morishima T., Mattsuno S., Isomura S., Suzuki S. Anamnestic response in fecal IgA antibody production after rotaviral infection of infants. J. Infect. Dis. 1985, 152:398-400.
194. Yamazaki H., Tsutsumi H., Matsuda K., Nagai K., Ogra P.L., Chiba S. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. J. Gen. Virol. 1994, 75:2115-2119. (Pt 8).
195. Yan H., Lamm M.E., Bjorling E., Huang Y.T. Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model. J. Virol. 2002, 76(21):10972-10979.
196. Yao Q.Y., Rowe M., Morgan A.J., Sam C.K., Prasad U., Dang H., Zeng Y., Rickinson A.B. Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: Incidence and potential for virus neutralization. Int. J. Cancer 1991, 48:45-50.
197. Yap K.L., Ada G.L., McKensie I.F.C. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 1978, 273:238-239.
198. Youngman K.R., Franco M.A., Kuklin N.A., Rott L.S., Butcher E.C., Greenberg H.B. Correlation of tissue distribution, developmental phenotype, and intestinal homing recetpor expression of antigen-specific B cells during the murine antirotavirus immune response. J. Immunol. 2002, 168(5):2173-2181.
199. Yuan L., Saif L.J. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model. Vet. Immunol. Immunopathol. 2002, 87(3-4):147-160.
200. Yuan L., Ward L.A., Rosen B.I., To T.L., Saif L.J. Systemic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 1996, 70(5):3075-3083.
201. Zhaori G., Sun M., Faden H.S., Ogra P.L. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines. J. Infect. Dis. 1989, 159:1018-1024.
202. + effector T cells. J. Immunol. 2001, 167(3):1379-1386.
203. Zuercher A.W., Coffin S.E., Thurnheer M.C., Fundova P., Cebra J.J. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J. Immunol. 2002, 168(4):1796-1803.
204. Zuercher A.W., Jiang H.Q., Thurnheer M.C., Cuff C.F., Cebra J.J. Distinct mechanisms for cross-protection of the upper versus lower respiratory tract through intestinal priming. J. Immunol. 2002, 169(7):3920-3925.